NCT01730937 2026-01-28
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
Clinical Trials
7 trialsNCT00093457 2023-08-04
Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT00064350 2023-06-29
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT01576185 2016-05-17
Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01804374 2015-06-17
SERIO
Italian Sarcoma Group
Phase 2 Completed
NCT01158287 2014-12-31
Sorafenib. ICORG 06-41, V4
Cancer Trials Ireland
Phase 2 Completed
NCT00889057 2013-03-28
Sorafenib in Relapsed High Grade Osteosarcoma
Italian Sarcoma Group
Phase 2 Completed